| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/21/2004 | DE10307445A1 Use of D-tagatose as a flavor enhancer in foods, beverages, chewing gum and tablets |
| 10/21/2004 | DE102004016947A1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 10/21/2004 | CA2843439A1 Reversible pegylated drugs |
| 10/21/2004 | CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 10/21/2004 | CA2528001A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 10/21/2004 | CA2522206A1 Oral administration form for veterinary use |
| 10/21/2004 | CA2522115A1 A fluoroquinolone aqueous formulation of a ph between 4 and 7 comprising i.a. cyclodextrin, hydroxyacid |
| 10/21/2004 | CA2521603A1 Stable carprofen composition |
| 10/21/2004 | CA2520875A1 Methods for rational pegylation of proteins |
| 10/21/2004 | CA2520864A1 Lipid particles having asymmetric lipid coating and method of preparing same |
| 10/21/2004 | CA2520766A1 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 10/21/2004 | CA2520347A1 Prostaglandin compositions and their use for the treatment of vasospasm |
| 10/21/2004 | CA2519380A1 Compositions and method for treating microbial and parasitic infections in cattle and other animals |
| 10/21/2004 | CA2501222A1 Antibody recognizing antigen |
| 10/20/2004 | EP1469042A2 Pigment composition and use in cosmetic, food and pharmaceutical preparations |
| 10/20/2004 | EP1469009A2 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 10/20/2004 | EP1468698A2 Human quinone reductase 2 conjugates for adept and gdept |
| 10/20/2004 | EP1468697A1 Compositions containing piperacillin and tazobactam useful for injection |
| 10/20/2004 | EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
| 10/20/2004 | EP1468682A1 Therapeutic combinations comprising amlodipine and atorvastatin |
| 10/20/2004 | EP1468681A1 Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process |
| 10/20/2004 | EP1468679A2 Controlled release formulation containing tramadol |
| 10/20/2004 | EP1468676A2 Poly (vinyl alcohol) cryogel |
| 10/20/2004 | EP1468663A2 Oil-water mixed composition |
| 10/20/2004 | EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein |
| 10/20/2004 | EP1468295A2 Water- soluble derivatives of lipophilic drugs |
| 10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
| 10/20/2004 | EP1468036A2 Biodegradable polyketal polymers and methods for their formation and use |
| 10/20/2004 | EP1468005A2 Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
| 10/20/2004 | EP1467770A1 Pantoprazole cyclodextrin inclusion complexes |
| 10/20/2004 | EP1467769A1 A method for preparing resinates |
| 10/20/2004 | EP1467768A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue |
| 10/20/2004 | EP1467766A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions |
| 10/20/2004 | EP1467758A2 Methods for preparing immunoconjugates |
| 10/20/2004 | EP1467757A2 Use of antibodies against the muc18 antigen |
| 10/20/2004 | EP1467756A2 Methods for using anti-muc18 antibodies |
| 10/20/2004 | EP1467750A1 Orodispersible pharmaceutical composition comprising perindopril |
| 10/20/2004 | EP1467749A1 Thrombin derived peptides for promoting cardiac tissue repair |
| 10/20/2004 | EP1467748A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467744A2 Aqueous compositions containing metronidazole |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467737A1 Orally dispersible pharmaceutical piribedil composition |
| 10/20/2004 | EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 10/20/2004 | EP1467724A1 Orodispersible pharmaceutical composition comprising agomelatine |
| 10/20/2004 | EP1467720A2 Dna dosage forms |
| 10/20/2004 | EP1467718A1 Method of treatment of a patient requiring analgesia |
| 10/20/2004 | EP1467716A2 Polytartrate composition |
| 10/20/2004 | EP1467715A1 Formulations for oral administration of active compounds |
| 10/20/2004 | EP1467712A1 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic |
| 10/20/2004 | EP1467711A2 Dna dosage forms |
| 10/20/2004 | EP1467710A2 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support |
| 10/20/2004 | EP1467709A1 Drug nanoparticles from template emulsions |
| 10/20/2004 | EP1467707A1 Composition for easing human childbirth |
| 10/20/2004 | EP1467706A2 Dermal application system for aminolevulinic acid-derivatives |
| 10/20/2004 | EP1467701A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 10/20/2004 | EP1467622A2 Mitocidal compositions and methods |
| 10/20/2004 | EP1465643A4 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/20/2004 | EP1351669B1 Clear propofol compositions |
| 10/20/2004 | EP1305033B1 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 10/20/2004 | EP1232252A4 Reversibly inactivated acidified plasmin |
| 10/20/2004 | EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 10/20/2004 | EP1206268B1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 10/20/2004 | EP1183015B1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 10/20/2004 | EP1135112B1 An oral formulation for gastrointestinal drug delivery |
| 10/20/2004 | EP1115748B1 Carrageenan compositions, and processes for their production |
| 10/20/2004 | EP1109551A4 4-amino-3-mercapto-1,2,4-triazoles |
| 10/20/2004 | EP1091740B1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone |
| 10/20/2004 | EP1032592A4 Antimicrobial peptides |
| 10/20/2004 | EP1005351B1 Aqueous metal bicarbonate solutions for the treatment of osteoarthritis |
| 10/20/2004 | EP1003569B1 Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture |
| 10/20/2004 | EP0983087B1 Multivalent vaccine composition with mixed carrier |
| 10/20/2004 | EP0971701B1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 10/20/2004 | EP0904107B1 Immunoglobin-like domains with increased half lives |
| 10/20/2004 | EP0763354B1 Oil/water mixture composition |
| 10/20/2004 | CN1539006A Lanolin substitute, production method thereof and application of same |
| 10/20/2004 | CN1538855A Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
| 10/20/2004 | CN1538852A Mixtures of growth horomone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof and methods of making same |
| 10/20/2004 | CN1538851A Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and method of making same |
| 10/20/2004 | CN1538835A Ophthalmic depot fomulations for periocular or conjunctival administration |
| 10/20/2004 | CN1538825A Biodegradable injectable implants and related method of manufacture and use |
| 10/20/2004 | CN1538809A Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and methods of making same |
| 10/20/2004 | CN1537899A Water-containing composition comtaining N-alkyltartaric acid imide and N-alkylmaloy |
| 10/20/2004 | CN1537636A High-molecular mPEG-PLGA-mPEG accessory medicine for medicine use, prepu. method and application thereof |
| 10/20/2004 | CN1537635A Magnetic, high-molecular, nanometer micro-balls type medicine carrying system, and its prepn. method |
| 10/20/2004 | CN1537535A Freezing-dried composite contg. dexrazoxane and its prepn. method |
| 10/20/2004 | CN1171920C Graft copolymer of polyvinyl ester and its preparation method and use |
| 10/20/2004 | CN1171639C Medicinal compositions for oral use |
| 10/20/2004 | CN1171610C Traditional Chinese medcine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method |
| 10/20/2004 | CN1171593C Embedded musk and its preparing process |
| 10/20/2004 | CN1171588C Application of ivermectin for preparing medicine for treatment of seborrhea |
| 10/20/2004 | CN1171587C Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof |
| 10/20/2004 | CN1171583C Medical percutaneous preparation containing hydrophilic or salt form |
| 10/20/2004 | CN1171582C Oral pharmaceutical extended release dosage form |
| 10/19/2004 | US6806354 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 10/19/2004 | US6806256 Especially a bitter tasting antibiotic containing an artificial sweetener |
| 10/19/2004 | US6806255 Compounds and methods for modulating adhesion molecule function |
| 10/19/2004 | US6806247 Environmentally desirable for use as refrigerants, aerosol propellants, metered dose inhalers, blowing agents for polymer foam, heat transfer media, and gaseous dielectrics |
| 10/19/2004 | US6806243 Ophthalmic solution and contact lens solution |